UNIVERSITY SCIENTIST
RECOGNISED FOR
ENTREPRENEURIAL SPIRIT
Dr Curtis Dobson
AWARDS
16
Dr Curtis Dobson won the
Commercial Innovator of the
Year award at the BBSRC's
Fostering Innovation Awards
2014. The awards were
presented at a high-profile
event in London on 20 March
2014 in front of an invited
audience of leading figures
from the worlds of investment,
industry, government, charity
and academia.
He scooped the £15,000 award
is recognition of the successful
transfer of technology and
resultant healthcare impact over
many years with two University
spin-out companies based on
Dr Dobson's research: Ai2 Ltd
and Microsensor Ltd.
Ai2 Ltd has developed
anti-infective peptide technology
for use in ophthalmics and in
medical devices, such as urinary
catheters and stents as well
being utilised in wound dressings
and consumer products.
Microsensor Ltd is developing a
new approach to the early
detection of medical device
infection and environmental
monitoring The technology is
simple, inexpensive and robust,
providing a clear 'yes/no' signal,
indicating a clinically or
industrially relevant level of
infection on a surface, thereby
enabling early intervention.
Dr Curtis Dobson said: "Being
recognised by this BBSRC award
is a privilege and an honour,
and further validates our efforts
to tackle resistant infection,
which impacts so many people
throughout the UK and beyond.
The additional funds will help
us accelerate commercialisation
of our latest technologies,
ultimately delivering benefits to
patients sooner."
Professor Ian Kimber, FLS's
Associate Dean for Business
Development commented: "This
is a remarkable achievement
and is a testament to the
industry and innovation of
Curtis and his co-workers. It is a
reflection also of the emphasis
we place on ensuring that the
fruits of our substantial
investment in research
deliver valuable products
and opportunities."
UMIC
®
UMIP
®
UMI
3
www.bbsrc.ac.uk
